Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) stock tumbled over 26 percent in the past one month despite the company announcing positive data about its lead candidate Azedra late last month. The drug was found performing satisfactorily in its Phase 2b trial. The test was designed to assess the efficacy and safety of the treatment in patients suffering from malignant and/or recurrent pheochromocytoma....More>>>
In my last update, I talked about gold’s reaction to the Fed rate hike. The rate hike (though nearly unanimously expected) caused the dollar to rally, thereby weighing on gold.
That led to even further negative sentiment, pulling gold down a further $30 per ounce from $1,160 to the $1,130 range. The price of gold today is up slightly 0.27%, but it is still trading....More>>>
Hywind wind farm concept. Five turbines will be placed off the east coast of Scotland, near Peterhead. They will each be anchored with three suction anchors and linked together to send electricity to shore to power 22,000 households. Source: Statoil.
Seeking Alpha contributor Michael Fitzsimmons has summarized Statoil’s (NYSE:STO) Q2 results, which he suggests show that the company....More>>>
It was a wild week filled with big moves both up and down yet the major index managed to finish the week higher ahead of next week’s Fed meeting.
The S&P 500 rose 0.5% this week after declining 0.4% to2,139.16 today, while the Dow Jones Industrial Average advanced 0.2% this week after falling 88.68 points, or 0.5%, to 18,123.80 today. The Nasdaq Composite....More>>>
Oil futures ended a four-day string of gains Thursday, with the U.S. benchmark failing to sustain a bounce after data showed a rise in domestic crude-oil inventories.
On the New York Mercantile Exchange, light, sweet crude futures for delivery in February ....More>>>
Shares of Biogen (BIIB) were halted earlier today after the Wall Street Journal reported that Merck (MRK) and Allergan (AGN) are interested in buying the biotech giant. The Journal’s Dana Mattioli, Jonathan Rockoff, and Dana Cimilluca report:
Bloomberg News/Scott Eisen
Biotechnology giant Biogen Inc. has drawn takeover interest from drug companies including Merck &....More>>>
Nike (NKE) was up more than 3% in after-hours trading yesterday after releasing its earnings after the close. Now it’s up just 0.4%. What gives? Morgan Stanley’s Jay Sole and team explain how Nike was “caught offside”:
First, Nike N. Am. futures growth decelerated 500 bps q/q. The implication is Nike is either losing share or the athletic....More>>>
Clinical stage biopharmaceutical company Biohaven Pharmaceuticals (Pending:BHVN) has filed to raise $125 million in an IPO by selling 8.33 million common shares at a midpoint price of $15.00 per share.
Biohaven has a large pipeline of treatments under development for neurological conditions.
The company is in or nearing Phase 3 trials for its lead candidates,....More>>>
Everything has gone up. The "Trump Bump" has turned into a frenzy… Nothing is cheap anymore… right? My friend, you are not looking hard enough… Something cheap (and hated) is always out there! Sometimes you just have to look past the headlines to find it… For example, did you know there is an asset out there – that trades in the....More>>>
The rally in equities had stolen much of the speculative demand from gold, and any pullback promised to send investors running back into gold. This is happening at this very moment, explains Brien Lundin, editor of Gold Newsletter.
Coincidental to all of this, we’ll soon see the end of two events — the Chinese New_Year and the currency illiquidity crisis in India — that....More>>>